Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.
Int J Cardiol. 2013 Sep 30;168(2):1360-3. doi: 10.1016/j.ijcard.2012.12.011. Epub 2012 Dec 29.
The components of CHADS2 score were reported to be important risk factors for the development of atrial fibrillation (AF). The goal of the current study was to investigate whether the CHADS2 score was a useful scheme in predicting new-onset AF. Furthermore, we aimed to use the CHADS2 scoring system to estimate the individual risk in developing AF for patients with different comorbidities.
From January 1, 2000 to December 31, 2001, a total of 702,502 patients older than 18 years old and who had no history of cardiac arrhythmias were identified from the "National Health Insurance Research Database" released by the Taiwan National Health Research Institutes. The CHADS2 score was calculated for every patient. Finally, 628,807 (score 0), 47,039 (score 1), 15,655 (score 2), 6843 (score 3), 3315 (score 4), 790 (score 5) and 53 (score 6) patients were studied and followed for the occurrences of AF.
During a follow-up of 9.0 ± 2.2 years, there were 9187 (1.3%) patients experiencing new-onset AF. The incidence of AF was 1.5 per 1000 patient-years. The incidence increased from 0.8 per 1000 patient-years for patients with a CHADS2 score of 0 to 34.6 per 1000 patient-years for those with a CHADS2 score of 6. After an adjustment for the gender and comorbidities, the hazard ratio (95% confidence interval) of each increment of the CHADS2 score in predicting AF was 2.342 (2.309-2.375; p<0.001).
The CHADS2 score, consisting of an age >75 and several clinical risk factors was useful in risk estimation and stratification of new-onset AF.
CHADS2 评分的各项组成被报道为心房颤动(AF)发生的重要危险因素。本研究旨在探讨 CHADS2 评分是否为预测新发 AF 的有用方案。此外,我们旨在使用 CHADS2 评分系统评估不同合并症患者发生 AF 的个体风险。
从 2000 年 1 月 1 日至 2001 年 12 月 31 日,从台湾国家健康研究所发布的“国家健康保险研究数据库”中确定了 702502 名年龄大于 18 岁且无心律失常病史的患者。为每位患者计算 CHADS2 评分。最后,研究并随访了 628807 名(评分 0)、47039 名(评分 1)、15655 名(评分 2)、6843 名(评分 3)、3315 名(评分 4)、790 名(评分 5)和 53 名(评分 6)患者新发 AF 的发生情况。
在 9.0±2.2 年的随访期间,有 9187 名(1.3%)患者新发 AF。AF 的发生率为每 1000 患者年 1.5 例。AF 的发生率从 CHADS2 评分为 0 的患者的每 1000 患者年 0.8 例增加到 CHADS2 评分为 6 的患者的每 1000 患者年 34.6 例。在调整性别和合并症后,CHADS2 评分每增加 1 分预测 AF 的风险比(95%置信区间)为 2.342(2.309-2.375;p<0.001)。
由年龄>75 岁和几个临床危险因素组成的 CHADS2 评分可用于评估新发 AF 的风险和分层。